Pulmonx (LUNG) reported second-quarter 2026 revenue of $22.8 million, down 5% from $23.9 million a year earlier. The company posted a net loss of $10.1 million, or $0.24 per share, compared with a net loss of $15.2 million, or $0.38 per share, in the same period of 2025.
Pulmonx said U.S. revenue was $14.2 million, down 4%, while international revenue was $8.6 million, down 6%. The company maintained its full-year 2026 revenue outlook of $90 million to $92 million.
- Second-quarter worldwide revenue was $22.8 million, down 5% year over year.
- Gross profit was $17.7 million, with gross margin of 78%.
- Operating expenses fell 16% to $26.8 million.
- Cash and cash equivalents totaled $55.8 million as of June 30, 2026.
- Full-year 2026 gross margin is expected to be approximately 76%.
$LUNG Insider Trading Activity
$LUNG insiders have traded $LUNG stock on the open market 27 times in the past 6 months. Of those trades, 0 have been purchases and 27 have been sales.
Here’s a breakdown of recent trading of $LUNG stock by insiders over the last 6 months:
- GLENDON E. III FRENCH (President and CEO) has made 0 purchases and 3 sales selling 67,813 shares for an estimated $96,972.
- DAVID AARON LEHMAN (GENERAL COUNSEL) has made 0 purchases and 8 sales selling 26,831 shares for an estimated $39,973.
- SRIKANTH RADHAKRISHNAN (Chief Science &Techn. Officer) has made 0 purchases and 8 sales selling 24,980 shares for an estimated $37,316.
- GEOFFREY BERAN ROSE (CHIEF COMMERCIAL OFFICER) has made 0 purchases and 8 sales selling 15,755 shares for an estimated $23,412.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.
$LUNG Hedge Fund Activity
We have seen 54 institutional investors add shares of $LUNG stock to their portfolio, and 49 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- SILVERCREST ASSET MANAGEMENT GROUP LLC removed 1,264,233 shares (-100.0%) from their portfolio in Q1 2026, for an estimated $1,630,860
- SOLEUS CAPITAL MANAGEMENT, L.P. added 750,000 shares (+36.8%) to their portfolio in Q1 2026, for an estimated $967,500
- BANK OF AMERICA CORP /DE/ added 439,027 shares (+60.3%) to their portfolio in Q1 2026, for an estimated $566,344
- AQR CAPITAL MANAGEMENT LLC added 298,659 shares (+506.9%) to their portfolio in Q1 2026, for an estimated $385,270
- STONEPINE CAPITAL MANAGEMENT, LLC added 281,888 shares (+58.0%) to their portfolio in Q1 2026, for an estimated $363,635
- BARCLAYS PLC added 211,184 shares (+44.7%) to their portfolio in Q1 2026, for an estimated $272,427
- MORGAN STANLEY removed 166,907 shares (-4.0%) from their portfolio in Q1 2026, for an estimated $215,310
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
